Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans
- PMID: 19546980
- DOI: 10.1364/oe.15.006696
Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans
Abstract
We present three-dimensional (3D) in vivo images of human breast cancer based on fluorescence diffuse optical tomography (FDOT). To our knowledge, this work represents the first reported 3D fluorescence tomography of human breast cancer in vivo. In our protocol, the fluorophore Indocyanine Green (ICG) is injected intravenously. Fluorescence excitation and detection are accomplished in the soft-compression, parallel-plane, transmission geometry using laser sources at 786 nm and spectrally filtered CCD detection. Phantom and in vivo studies confirm the signals are due to ICG fluorescence, rather than tissue autofluorescence and excitation light leakage. Fluorescence images of breast tumors were in good agreement with those of MRI, and with DOT based on endogenous contrast. Tumorto- normal tissue contrast based on ICG fluorescence was two-to-four-fold higher than contrast based on hemoglobin and scattering parameters. In total the measurements demonstrate that FDOT of breast cancer is feasible and promising.
Similar articles
-
Unmixing dynamic fluorescence diffuse optical tomography images with independent component analysis.IEEE Trans Med Imaging. 2011 Sep;30(9):1591-604. doi: 10.1109/TMI.2011.2134865. Epub 2011 May 31. IEEE Trans Med Imaging. 2011. PMID: 21632297
-
Light illumination and detection patterns for fluorescence diffuse optical tomography based on compressive sensing.IEEE Trans Image Process. 2014 Jun;23(6):2609-24. doi: 10.1109/TIP.2014.2300756. IEEE Trans Image Process. 2014. PMID: 24815621
-
Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging.Med Phys. 2003 Feb;30(2):235-47. doi: 10.1118/1.1534109. Med Phys. 2003. PMID: 12607841 Clinical Trial.
-
Optical imaging of breast tumors and of gastrointestinal cancer by laser-induced fluorescence.Recent Results Cancer Res. 2013;187:331-50. doi: 10.1007/978-3-642-10853-2_11. Recent Results Cancer Res. 2013. PMID: 23179887 Review.
-
[A new approach for studying the retinal and choroidal circulation].Nippon Ganka Gakkai Zasshi. 2004 Dec;108(12):836-61; discussion 862. Nippon Ganka Gakkai Zasshi. 2004. PMID: 15656089 Review. Japanese.
Cited by
-
Dual-tracer background subtraction approach for fluorescent molecular tomography.J Biomed Opt. 2013 Jan;18(1):16003. doi: 10.1117/1.JBO.18.1.016003. J Biomed Opt. 2013. PMID: 23292612 Free PMC article.
-
Near-Infrared Optical Imaging Noninvasively Detects Acutely Damaged Muscle.Am J Pathol. 2016 Oct;186(10):2692-700. doi: 10.1016/j.ajpath.2016.06.019. Epub 2016 Aug 24. Am J Pathol. 2016. PMID: 27565039 Free PMC article.
-
Portable, parallel 9-wavelength near-infrared spectral tomography (NIRST) system for efficient characterization of breast cancer within the clinical oncology infusion suite.Biomed Opt Express. 2016 May 16;7(6):2186-201. doi: 10.1364/BOE.7.002186. eCollection 2016 Jun 1. Biomed Opt Express. 2016. PMID: 27375937 Free PMC article.
-
Separating structures of different fluorophore concentrations by principal component analysis on multispectral excitation-resolved fluorescence tomography images.Biomed Opt Express. 2013 Aug 29;4(10):1829-45. doi: 10.1364/BOE.4.001829. eCollection 2013. Biomed Opt Express. 2013. PMID: 24156047 Free PMC article.
-
Improved detection limits using a hand-held optical imager with coregistration capabilities.Biomed Opt Express. 2010 Jul 15;1(1):126-134. doi: 10.1364/BOE.1.000126. Biomed Opt Express. 2010. PMID: 21258452 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources